Tenoxicam compared with diclofenac in patients with ankylosing spondylitis

References

• Astorga G. Double-blind, parallel clinical trial of tenoxicam (Ro 12–0068) versus piroxicam in patients with ankylosing spondylitis. Eur J. Rheumatol. Inflamm. 1987; 9: 70, 731. Astorga G. Double-blind, parallel clinical trial of tenoxicam (Ro 12–0068) versus piroxicam in patients with ankylosing spondylitis. Eur J. Rheumatol. Inflamm. 1987; 9: 70, 73
   PubMedGoogle Scholar
• Berg D., Scholz H.-J. The effect of 20 mg tenoxicam daily for eight weeks in patients with definite rheumatoid arthritis with particular consideration of quantified (ROI) scintigraphic joint measurements. Litera Rheumatol. 1987; 7: 14, 182. Berg D., Scholz H.-J. The effect of 20 mg tenoxicam daily for eight weeks in patients with definite rheumatoid arthritis with particular consideration of quantified (ROI) scintigraphic joint measurements. Litera Rheumatol. 1987; 7: 14, 18
   Google Scholar
• Bird H. A., Francis R. J., Le Gallez P., Hill J., Dixon J. S., Allen J. G., Wright V. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly. Eur. J. Rheumatol. Inflamm. 1985; 8: 60, 693. Bird H. A., Francis R. J., Le Gallez P., Hill J., Dixon J. S., Allen J. G., Wright V. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly. Eur. J. Rheumatol. Inflamm. 1985; 8: 60, 69
   PubMed Web of Science ®Google Scholar
• Bird H. A., Hill J., Lowe J. R., Wright V. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis. Eur. J. Rheumatol. Inflamm. 1985; 7: 28, 324. Bird H. A., Hill J., Lowe J. R., Wright V. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis. Eur. J. Rheumatol. Inflamm. 1985; 7: 28, 32
   Google Scholar
• Bird H. A., Le Gallez P., Astbury C., Looi D., Wright V. A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis. Pharmathera-peutica 1986; 4: 457, 4625. Bird H. A., Le Gallez P., Astbury C., Looi D., Wright V. A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis. Pharmathera-peutica 1986; 4: 457, 462
   PubMedGoogle Scholar
• Bradshaw D., Cashin C. H., Kennedy A. J., Roberts N. A. Pharmacodynamics of tenoxicam: pharmacological and biochemical activities in animals and. in vitro. Agents Actions 1984; 15: 569, 5776. Bradshaw D., Cashin C. H., Kennedy A. J., Roberts N. A. Pharmacodynamics of tenoxicam: pharmacological and biochemical activities in animals and. in vitro. Agents Actions 1984; 15: 569, 577
   PubMedGoogle Scholar
• Calin A. Ankylosing spondylitis. “Textbook of Rheumatology”, W. N. Kelly, E. D. Harris, S. Ruddy, C. B. Sledge. Saunders, Philadelphia 1989; 1021–10527. Calin A. Ankylosing spondylitis. “Textbook of Rheumatology”, W. N. Kelly, E. D. Harris, S. Ruddy, C. B. Sledge. Saunders, Philadelphia 1989; 1021–1052
   Google Scholar
• Filho A. P. M., Sidi A. Long term study with Ro 12–0068 (tenoxicam) in the treatment of rheumatoid arthritis. Eur. J. Rheumatol. Inflamm. 1985; 8: 3, 88. Filho A. P. M., Sidi A. Long term study with Ro 12–0068 (tenoxicam) in the treatment of rheumatoid arthritis. Eur. J. Rheumatol. Inflamm. 1985; 8: 3, 8
   PubMedGoogle Scholar
• Fiszman P., Perpetuo J. B. R., Franco J. S., Pernambuco J. C., Rubinstein J., Sidi A. Rectal administration of tenoxicam for the treatment of rheumatoid arthritis and arthrosis. Euc J. Rheumatol. Inflamm. 1985; 8: 9, 149. Fiszman P., Perpetuo J. B. R., Franco J. S., Pernambuco J. C., Rubinstein J., Sidi A. Rectal administration of tenoxicam for the treatment of rheumatoid arthritis and arthrosis. Euc J. Rheumatol. Inflamm. 1985; 8: 9, 14
   PubMedGoogle Scholar
• Gross W. Long-term treatment of rheumatoid arthritis: results of a two-year study with tenoxicam. Eur. J. Rheumatol. Inflamm. 1987; 9: 102, 10410. Gross W. Long-term treatment of rheumatoid arthritis: results of a two-year study with tenoxicam. Eur. J. Rheumatol. Inflamm. 1987; 9: 102, 104
   PubMedGoogle Scholar
• Heintz R. C., Guentert T. W., Enrico J. F., Dubach U. C., Brandt R., Jeunet R S. Pharmacokinetics of tenoxicam in healthy human volunteers. Eur. J. Rheumatol. Inflamm. 1984; 4: 33, 4411. Heintz R. C., Guentert T. W., Enrico J. F., Dubach U. C., Brandt R., Jeunet R S. Pharmacokinetics of tenoxicam in healthy human volunteers. Eur. J. Rheumatol. Inflamm. 1984; 4: 33, 44
   Google Scholar
• Horber R P., Guentert T. W., Weidekamm E., Heiztnann P., Descoeudres C., Frey F. J. Pharmacokinetics of tenoxicam in patients with impaired renal function. Eur. J. Clin. Pharmacol. 1986; 29: 697, 70112. Horber R P., Guentert T. W., Weidekamm E., Heiztnann P., Descoeudres C., Frey F. J. Pharmacokinetics of tenoxicam in patients with impaired renal function. Eur. J. Clin. Pharmacol. 1986; 29: 697, 701
   PubMed Web of Science ®Google Scholar
• Liauw L., Moscaritola J. D., Burcher J. Diclofenac. “Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Use”, A. J. Lewis, D. E. Furst. Marcel Dekker, New York 1987; 329–34713. Liauw L., Moscaritola J. D., Burcher J. Diclofenac. “Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Use”, A. J. Lewis, D. E. Furst. Marcel Dekker, New York 1987; 329–347
   Google Scholar
• Ott H. Tenoxicam in the treatment of osteoarthritis. Eur J. Rheumatol. Inflamm. 1985; 8: 39, 4614. Ott H. Tenoxicam in the treatment of osteoarthritis. Eur J. Rheumatol. Inflamm. 1985; 8: 39, 46
   PubMedGoogle Scholar
• Romberg Ø. Tenoxicam (Ro 12–0068) in ankylosing spondylitis. Eur. J. Rheumatol. Inflamm. 1987; 9: 122, 12515. Romberg Ø. Tenoxicam (Ro 12–0068) in ankylosing spondylitis. Eur. J. Rheumatol. Inflamm. 1987; 9: 122, 125
   PubMedGoogle Scholar
• Standel W., Josenhants G. Clinical evaluation of tenoxicam i. osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Eur. J. Rheumatol. Inflamm. 1985; 8: 28, 3816. Standel W., Josenhants G. Clinical evaluation of tenoxicam i. osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Eur. J. Rheumatol. Inflamm. 1985; 8: 28, 38
   PubMedGoogle Scholar
• Valdés E. R, Barclay C. A., Traballi C. A. Clinical evaluation of the thieno-thiazine derivative, Ro 12–0068, in rheumatoid arthritis. Curr. Ther. Res. 1982; 31: 402, 40717. Valdés E. R, Barclay C. A., Traballi C. A. Clinical evaluation of the thieno-thiazine derivative, Ro 12–0068, in rheumatoid arthritis. Curr. Ther. Res. 1982; 31: 402, 407
   Web of Science ®Google Scholar
• Waterworth R. R, Waterworth S. M., Taylor K. M. A comparison of tenoxicam and piroxicam in a long-term clinical study in patients with osteoarthritis of hip or knee joints. Euc J. Rheumatol. Inflamm. 1985; 8: 21, 2718. Waterworth R. R, Waterworth S. M., Taylor K. M. A comparison of tenoxicam and piroxicam in a long-term clinical study in patients with osteoarthritis of hip or knee joints. Euc J. Rheumatol. Inflamm. 1985; 8: 21, 27
   PubMed Web of Science ®Google Scholar